Home › Emphysema › Illinois
Emphysema clinical trials in Illinois
8 studies for Emphysema are looking for participants at sites in Illinois.
Cities in Illinois
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Axis Clinical Trials - Westchester, Westchester
RecruitingPhase 2
Ages 40 to 75 · All sexes · Updated Nov 5, 2026 · NCT07759245Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- University of Chicago, Chicago
- OSF St Francis Medical Center, Peoria
Recruiting
Ages 40 to 84 · All sexes · Updated Oct 19, 2026 · NCT06891755STRIVE Post-Market Registry Study
- Northwestern University, Division of Pulmonary and Critical Care Medicine, Chicago
- University of Chicago, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT04302272A Multi Center Study Testing a New Implant for Adults With Severe Emphysema
- Northwestern University, Chicago
Recruiting
Ages 22 and older · All sexes · Updated Oct 14, 2026 · NCT07119229COPD Resources, Education, and Activity Designed for You Study
- Rush University Medical Center, Chicago
Recruiting
Ages 40 and older · All sexes · Updated Oct 8, 2026 · NCT07125053An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Northwestern University, Chicago
- University of Chicago Medical Center, Chicago
- OSF Saint Francis Medical Center, Peoria
Recruiting
Ages 40 to 80 · All sexes · Updated Sep 17, 2026 · NCT06035120PiMZ Longitudinal Cohort (PiMZ Logic)
- University of Chicago, Chicago
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jan 16, 2026 · NCT06505603Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- University of Chicago, Chicago
- Walgreens, Deerfield
- Springfield Clinic, LLP, Springfield
RecruitingObservational study
Ages 50 and older · All sexes · Updated Aug 5, 2025 · NCT06122077From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.